Thompson Tamar

Thompson Tamar is listed in filings as Director at Avidity Biosciences Inc. This profile follows SEC Form 4 activity through Feb 27, 2026, including 10 public disclosures. Recent filings connect the profile to Avidity Biosciences Inc (RNAM) and Catalyst Pharmaceuticals, Inc. (CPRX). The current snapshot covers public activity from Dec 11, 2024 to Feb 27, 2026. Reported amounts are shown as $539.0K to $274.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.